Viewing nowK-Met Extended-Release Tablet (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 201906866 · Approved 2019.09.26 · Insurance code 665002760
Treatment of type 2 diabetes mellitus in adults not adequately controlled by diet and exercise
This medication is used for patients with type 2 diabetes who do not achieve adequate blood sugar control through diet and exercise alone, particularly in those who are overweight. It can be used alone or in combination with other oral hypoglycemic agents or insulin. This aids in effective blood sugar control and contributes to diabetes management. The treatment regimen is adjusted according to the patient's health status, and it is used to stabilize blood sugar levels.
The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is one 500mg extended-release metformin hydrochloride tablet once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already being treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking 2000mg or more per day of immediate-release metformin tablets. - At treatment initiation and during dose adjustment, fasting blood glucose should be measured to assess the response to this medicine and determine the minimum effective dose. Blood glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine should be discontinued immediately.
This medication is used for the treatment of diabetes and may rarely cause a serious condition called lactic acidosis, so caution is required. If taken with other diabetes medications, there is a possibility of hypoglycemia, thus careful monitoring of blood sugar levels is needed. Patients with moderate to severe impaired renal function, dehydration, severe infections, heart failure, or acute conditions affecting kidney function such as acute myocardial infarction should not take this medication. When undergoing tests involving radiocontrast iodine agents, this medication should be discontinued prior to the examination and can be resumed only after normal kidney function is confirmed. Patients with allergies to this medication, type 1 diabetes, diabetic ketoacidosis, or other specific metabolic disorders should not use it. Severe infections or trauma, pre-and post-surgery, malnutrition, liver dysfunction, excessive alcohol consumption, etc., may necessitate temporary discontinuation of this medication. Patients with irregular eating patterns, excessive exercise, or concurrent use of interacting medications should use this medication cautiously as there is a risk of lactic acidosis and hypoglycemia. During treatment, side effects such as vitamin B12 deficiency, impaired taste, gastrointestinal disturbances (nausea, vomiting, diarrhea, abdominal pain, etc.), and skin rashes may occur. If any unusual symptoms arise, consultation with a physician is advised. This medication is excreted by the kidneys, so regular monitoring of kidney function is necessary, and treatment should be discontinued if function worsens. Alcohol can increase the risk of side effects from this medication, so excessive drinking should be avoided during treatment. During pregnancy, careful consideration of the potential effects on the fetus is necessary, and it is not recommended while breastfeeding. Elderly patients may have decreased renal function; hence, dosage should be adjusted accordingly and kidney function should be monitored regularly. In case of overdose, blood dialysis may be used to remove the drug, so medical attention should be sought immediately. Maintaining regular meals and exercise along with regular blood sugar and kidney function checks is very important during treatment. The tablets should be swallowed whole and not crushed or chewed. Additionally, several medications may interact with this drug, so be sure to inform healthcare providers about any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the drug's efficacy.
White, double convex, rectangular extended-release tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.